Cargando…

Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration

AIMS: Residual beta‐cell secretion in type 1 diabetes is commonly assessed by area‐under‐curve of plasma C‐peptide concentration (AUC(Cpep)) following mixed‐meal tolerance test (MMTT). We aimed to investigate alternative measures of beta‐cell responsiveness. METHODS: We analyzed data from 32 youth (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Yue, Willemsen, Ruben H., Wilinska, Malgorzata E., Tauschmann, Martin, Dunger, David B., Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons A/S 2019
Materias:	Type 1 Diabetes: Pathophysiology and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487945/ https://www.ncbi.nlm.nih.gov/pubmed/30652426 http://dx.doi.org/10.1111/pedi.12816

Ejemplares similares

Increased tissue factor activity promotes thrombin generation at type 1 diabetes onset in children
por: Jasser‐Nitsche, Hildegard, et al.
Publicado: (2020)

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results
por: Winkler, Christiane, et al.
Publicado: (2019)

Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
por: Cerqueiro Bybrant, Mara, et al.
Publicado: (2020)

Extended family history of type 1 diabetes in HLA‐predisposed children with and without islet autoantibodies
por: Kuusela, Salla, et al.
Publicado: (2020)

Human plasma‐derived alpha(1)‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study
por: Lagarde, William H., et al.
Publicado: (2020)

Viral infection‐related gene upregulation in monocytes in children with signs of β‐cell autoimmunity
por: Valta, Milla, et al.
Publicado: (2022)

Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes
por: Ilonen, Jorma, et al.
Publicado: (2022)

Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study
por: Antvorskov, Julie Christine, et al.
Publicado: (2020)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Insulin resistance relates to DKA severity and affects insulin requirement in children with type 1 diabetes at onset
por: Mastromauro, Concetta, et al.
Publicado: (2022)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
por: Pennant, Mary E., et al.
Publicado: (2008)

Type 1 Diabetes at a Crossroads!
por: Cefalu, William T., et al.
Publicado: (2015)

Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
por: Tauschmann, Martin, et al.
Publicado: (2016)

The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
por: Woerle, Hans Juergen, et al.
Publicado: (2012)

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Wellens, Martine J, et al.
Publicado: (2021)

Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: Raz, Itamar
Publicado: (2013)

GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
por: Donath, Marc Y., et al.
Publicado: (2013)

Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
por: Meier, Juris J., et al.
Publicado: (2013)

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2013)

Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?
por: Lyssenko, Valeriya, et al.
Publicado: (2013)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

N-Glycosylation of Carnosinase Influences Protein Secretion and Enzyme Activity: Implications for Hyperglycemia
por: Riedl, Eva, et al.
Publicado: (2010)

Mechanisms of Beta Cell Dysfunction Associated With Viral Infection
por: Petzold, Antje, et al.
Publicado: (2015)

Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
por: Menge, Björn A., et al.
Publicado: (2011)

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans
por: Xiao, Changting, et al.
Publicado: (2014)

Na(+)-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion
por: Gorboulev, Valentin, et al.
Publicado: (2012)

Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes
por: Wice, Burton M., et al.
Publicado: (2012)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

Severe Scratching in Spinocerebellar Ataxia 17: Another Case
por: Pauly, Martje G., et al.
Publicado: (2020)

Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients
por: Gupta, Harsh V., et al.
Publicado: (2020)

Late-Onset Tay-Sachs Disease - expanding the clinical phenotype
por: Lefter, Stela, et al.
Publicado: (2023)

Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes
por: Saleh, Nada M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fcmvmighfd5pfrk5d17mu4d10e